1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Vaccines & Therapeutics Market Size Growth Rate by Type (2022-2028)
1.2.2 COVID-19 Vaccines
1.2.3 COVID-19 Therapeutics
1.3 Market by Application
1.3.1 Global COVID-19 Vaccines & Therapeutics Market Share by Application (2022-2028)
1.3.2 Children
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global COVID-19 Vaccines & Therapeutics Market Size
2.2 COVID-19 Vaccines & Therapeutics Market Size by Regions
2.2.1 COVID-19 Vaccines & Therapeutics Growth Rate by Regions (2022-2028)
2.2.2 COVID-19 Vaccines & Therapeutics Market Share by Regions (2022-2028)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 COVID-19 Vaccines & Therapeutics Revenue by Players (2022 & 2028)
3.2 COVID-19 Vaccines & Therapeutics Key Players Headquarters and Area Served
3.3 Key Players COVID-19 Vaccines & Therapeutics Product/Solution/Service
3.4 Date of Enter into COVID-19 Vaccines & Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global COVID-19 Vaccines & Therapeutics Market Size by Type (2022-2028)
4.2 Global COVID-19 Vaccines & Therapeutics Market Size by Application (2022-2028)
5 North America
5.1 North America COVID-19 Vaccines & Therapeutics Market Forecast (2022-2028)
5.2 COVID-19 Vaccines & Therapeutics Key Players in North America
5.3 North America COVID-19 Vaccines & Therapeutics Market Size by Type
5.4 North America COVID-19 Vaccines & Therapeutics Market Size by Application
6 Europe
6.1 Europe COVID-19 Vaccines & Therapeutics Market Forecast (2022-2028)
6.2 COVID-19 Vaccines & Therapeutics Key Players in Europe
6.3 Europe COVID-19 Vaccines & Therapeutics Market Size by Type
6.4 Europe COVID-19 Vaccines & Therapeutics Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific COVID-19 Vaccines & Therapeutics Market Forecast (2022-2028)
7.2 COVID-19 Vaccines & Therapeutics Key Players in Asia-Pacific
7.3 Asia-Pacific COVID-19 Vaccines & Therapeutics Market Size by Type
7.4 Asia-Pacific COVID-19 Vaccines & Therapeutics Market Size by Application
8 Rest of World
8.1 Latin America
8.1.1 Latin America COVID-19 Vaccines & Therapeutics Market Analysis
8.1.2 Key Players in Latin America
8.2 Middle East & Africa
8.2.1 Middle East & Africa COVID-19 Vaccines & Therapeutics Market Analysis
8.2.2 Key Players in Middle East & Africa
9 International Player Profiles
9.1 Pfizer
9.1.1 Pfizer Company Details
9.1.2 Pfizer Description and Business Overview
9.1.3 Pfizer COVID-19 Vaccines & Therapeutics Introduction
9.1.4 Pfizer Revenue in COVID-19 Vaccines & Therapeutics Business (2022 & 2028)
9.1.5 Pfizer Recent Development
9.2 Moderna Therapeutics
9.2.1 Moderna Therapeutics Company Details
9.2.2 Moderna Therapeutics Description and Business Overview
9.2.3 Moderna Therapeutics COVID-19 Vaccines & Therapeutics Introduction
9.2.4 Moderna Therapeutics Revenue in COVID-19 Vaccines & Therapeutics Business (2022 & 2028)
9.2.5 Moderna Therapeutics Recent Development
9.3 AstraZeneca
9.3.1 AstraZeneca Company Details
9.3.2 AstraZeneca Description and Business Overview
9.3.3 AstraZeneca COVID-19 Vaccines & Therapeutics Introduction
9.3.4 AstraZeneca Revenue in COVID-19 Vaccines & Therapeutics Business (2022 & 2028)
9.3.5 AstraZeneca Recent Development
9.4 Janssen
9.4.1 Janssen Company Details
9.4.2 Janssen Description and Business Overview
9.4.3 Janssen COVID-19 Vaccines & Therapeutics Introduction
9.4.4 Janssen Revenue in COVID-19 Vaccines & Therapeutics Business (2022 & 2028)
9.4.5 Janssen Recent Development
9.5 Novavax
9.5.1 Novavax Company Details
9.5.2 Novavax Description and Business Overview
9.5.3 Novavax COVID-19 Vaccines & Therapeutics Introduction
9.5.4 Novavax Revenue in COVID-19 Vaccines & Therapeutics Business (2022 & 2028)
9.5.5 Novavax Recent Development
9.6 Gilead Sciences
9.6.1 Gilead Sciences Company Details
9.6.2 Gilead Sciences Description and Business Overview
9.6.3 Gilead Sciences COVID-19 Vaccines & Therapeutics Introduction
9.6.4 Gilead Sciences Revenue in COVID-19 Vaccines & Therapeutics Business (2022 & 2028)
9.6.5 Gilead Sciences Recent Development
9.7 Eli Lilly and Company
9.7.1 Eli Lilly and Company Company Details
9.7.2 Eli Lilly and Company Description and Business Overview
9.7.3 Eli Lilly and Company COVID-19 Vaccines & Therapeutics Introduction
9.7.4 Eli Lilly and Company Revenue in COVID-19 Vaccines & Therapeutics Business (2022 & 2028)
9.7.5 Eli Lilly and Company Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
